Edition:
United States

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

35.89USD
12:59pm EST
Change (% chg)

$0.15 (+0.42%)
Prev Close
$35.74
Open
$35.68
Day's High
$36.25
Day's Low
$35.56
Volume
29,715
Avg. Vol
133,758
52-wk High
$37.49
52-wk Low
$15.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.630
Jun '17 0.00 -0.647
Mar '17 0.00 -0.517
FY 2016 Dec '16 0.00 -0.551
Sep '16 0.00 -0.526
Jun '16 0.00 -0.434
Mar '16 0.00 -0.372
FY 2015 Dec '15 0.00 -0.383
Sep '15 0.00 -0.357
Jun '15 0.00 -0.181
Mar '15 0.00 -0.085
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 0.00 0.00 0.00 20.19
Earnings (per share)
Quarter Ending Dec-17 4 -0.68 -0.65 -0.74 -0.51
Quarter Ending Mar-18 3 -0.82 -0.73 -0.89 --
Year Ending Dec-17 4 -2.48 -2.45 -2.53 -2.55
Year Ending Dec-18 5 -3.15 -2.33 -3.56 -2.60
LT Growth Rate (%) 1 34.60 34.60 34.60 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.51 34.69
P/E High - Last 5 Yrs. -- 40.52 45.18
P/E Low - Last 5 Yrs. -- 23.58 24.22
Beta -- 0.91 0.89
Price to Sales (TTM) -- 3.86 5.34
Price to Book (MRQ) 8.60 4.78 5.60
Price to Tangible Book (MRQ) 8.63 5.60 7.13
Price to Cash Flow (TTM) -- 22.78 23.62
% Owned Institutions 85.76 0.74 1.29

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.15 2.03
Dividend 5 Year Growth Rate -- 4.36 5.31
Payout Ratio(TTM) -- 46.51 45.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.31 6.92
Sales (TTM) vs TTM 1 Yr. Ago -- 4.66 5.15
Sales - 5 Yr. Growth Rate -- 10.14 10.37
EPS (MRQ) vs Qtr. 1 Yr. Ago -19.81 4.50 4.97
EPS (TTM) vs TTM 1 Yr. Ago -36.73 -- --
EPS - 5 Yr. Growth Rate -- 10.00 10.99
Capital Spending - 5 Yr. Growth Rate -- 15.21 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.54
Current Ratio (MRQ) 10.29 3.51 3.56
LT Debt to Equity (MRQ) 0.00 9.85 12.32
Total Debt to Equity (MRQ) 0.00 15.93 18.28
Interest Coverage (TTM) -- 49.08 43.76

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.99 54.71
Gross Margin - 5 Yr. Avg. -- 52.04 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.35 15.66
Operating Margin (TTM) -- 14.65 8.10
Operating Margin - 5 Yr. Avg. -- 14.46 11.31
Pre-Tax Margin (TTM) -- 15.12 8.94
Pre-Tax Margin - 5 Yr. Avg. -- 14.78 11.72
Net Profit Margin (TTM) -- 11.29 5.17
Net Profit Margin - 5 Yr. Avg. -- 11.10 8.00
Effective Tax Rate (TTM) -- 24.29 24.18
Effective Tax Rate - 5 Yr. Avg. -- 23.42 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 961,362,620 865,539,949
Net Income/Employee (TTM) -1,670,073 112,186,502 100,926,146
Receivable Turnover (TTM) -- 5.91 6.13
Inventory Turnover (TTM) -- 2.72 3.53
Asset Turnover (TTM) 0.00 1.00 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.57 11.93 11.39
Return on Assets - 5 Yr. Avg. -- 13.02 12.42
Return on Investment (TTM) -61.56 15.16 14.55
Return on Investment - 5 Yr. Avg. -- 17.03 16.27
Return on Equity (TTM) -62.11 16.57 16.05
Return on Equity - 5 Yr. Avg. -- 17.97 17.42
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -0.51 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aimmune Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 14.40 12.65 85 42
13 Week 86.44 75.45 97 15
26 Week 107.07 91.70 97 34
52 Week 43.30 21.56 81 20
YTD 74.77 50.66 90 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 85.76%
# of Holders: 146
Total Shares Held: 43,619,564
3 Mo. Net Change: 529,389
# New Positions: 15
# Closed Positions: 7
# Increased Positions: 63
# Reduced Positions: 43
# Net Buyers: 20
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.